1
|
Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
|
J Clin Oncol
|
2008
|
2.09
|
2
|
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.
|
Haematologica
|
2010
|
0.90
|
3
|
Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF).
|
Cancer Cell Int
|
2012
|
0.76
|